Ensign Peak Advisors’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$21.5M Sell
83,196
-7,021
-8% -$1.81M 0.04% 304
2025
Q1
$20.2M Sell
90,217
-4,692
-5% -$1.05M 0.04% 303
2024
Q4
$21.7M Sell
94,909
-211
-0.2% -$48.3K 0.04% 306
2024
Q3
$23.2M Buy
95,120
+9,410
+11% +$2.3M 0.04% 296
2024
Q2
$16.4M Buy
85,710
+13,324
+18% +$2.55M 0.03% 345
2024
Q1
$14.3M Buy
72,386
+19,829
+38% +$3.93M 0.03% 382
2023
Q4
$9.04M Buy
52,557
+42,571
+426% +$7.32M 0.02% 461
2023
Q3
$1.48M Sell
9,986
-66
-0.7% -$9.76K ﹤0.01% 945
2023
Q2
$2.2M Sell
10,052
-2,867
-22% -$626K ﹤0.01% 838
2023
Q1
$2.83M Hold
12,919
0.01% 723
2022
Q4
$2.69M Buy
12,919
+150
+1% +$31.2K 0.01% 724
2022
Q3
$2.79M Sell
12,769
-600
-4% -$131K 0.01% 675
2022
Q2
$2.8M Buy
13,369
+1,318
+11% +$276K 0.01% 691
2022
Q1
$2.92M Sell
12,051
-1,119
-8% -$271K 0.01% 734
2021
Q4
$3.43M Sell
13,170
-2,666
-17% -$694K 0.01% 778
2021
Q3
$4.17M Buy
15,836
+397
+3% +$105K 0.01% 730
2021
Q2
$3.81M Sell
15,439
-3,405
-18% -$839K 0.01% 767
2021
Q1
$3.66M Sell
18,844
-6,347
-25% -$1.23M 0.01% 771
2020
Q4
$5.35M Sell
25,191
-5,035
-17% -$1.07M 0.01% 586
2020
Q3
$5.18M Buy
30,226
+12,365
+69% +$2.12M 0.01% 621
2020
Q2
$3.43M Buy
17,861
+250
+1% +$48K 0.01% 724
2020
Q1
$2.59M Sell
17,611
-5,900
-25% -$869K 0.01% 725
2019
Q4
$3.64M Buy
+23,511
New +$3.64M 0.01% 752